Table 1.
Summary of the clinical pathological status of triple-negative cases (TNBC) and non triple-negative cases (non-TNBC)
| Characteristic | |
No. of patients (%) |
|
|---|---|---|---|
| TNBC (N = 42) | non-TNBC (N =298) | TOTAL | |
|
AGE AT DIAGNOSIS (y) | |||
| ≤ 40 |
15 (35.7%) |
49 (16.4%) |
64 (18.8%) |
| 41 ≤ y ≤ 49 |
13 (31.0%) |
113 (37.9%) |
126 (37.1%) |
| 50 ≤ y ≤ 65 |
13 (31.0%) |
107 (35.9%) |
120 (35.3%) |
| > 65 |
1 (2.4%) |
29 (9.7%) |
30 (8.8%) |
|
HISTOLOGY | |||
| DCIS |
3 (7.1%) |
35 (11.7%) |
38 (11.2%) |
| IDC |
35 (83.3%) |
232 (77.9%) |
267 (78.5%) |
| Others |
4 (9.5%) |
31 (10.4%) |
35 (10.3%) |
|
GRADE | |||
| 1 (well differentiated) |
0 (0.0%) |
7 (2.3%) |
7 (2.1%) |
| 2 (moderately differentiated) |
6 (14.3%) |
110 (36.9%) |
116 (34.1%) |
| 3 (poorly differentiated) |
32 (76.2%) |
151 (50.7%) |
183 (53.8%) |
| Not determined |
4 (9.5%) |
30 (10.1%) |
34 (10.0%) |
|
TUMOR SIZE (cm) | |||
| ≤ 2 |
12 (28.6%) |
109 (36.6%) |
121 (35.6%) |
| 2 < cm ≤ 5 |
15 (35.7%) |
99 (33.2%) |
114 (33.5%) |
| > 5 |
3 (7.1%) |
15 (5.0%) |
18 (5.3%) |
| Not determined |
12 (28.6%) |
75 (25.2%) |
87 (25.6%) |
|
LYMPH NODE INFILTRATION | |||
| Positive |
17 (40.5%) |
91 (30.5%) |
108 (31.8%) |
| Negative |
25 (59.5%) |
194 (65.1%) |
219 (64.4%) |
| Not determined |
0 (0.0%) |
13 (4.4%) |
13 (3.8%) |
|
p53 STATUS | |||
| Positive |
15 (35.7%) |
45 (15.1%) |
60 (17.6%) |
| Negative |
27 (64.3%) |
251 (84.2%) |
278 (81.8%) |
| Not determined | 0 (0.0%) | 2 (0.7%) | 2 (0.6%) |
Note: Percentage (%) indicates the percentage within the subgroup. DCIS ductal carcinoma in-situ, IDC invasive ductal carcinoma.